Katy McLaughlin
Psychiatry · Denver, CONPI 1255789772
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 331 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 29.0% of the total. 2025 is the largest year on record at $2,093, 3.8 times the $551 reported in 2021. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 331 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Tris Pharma Inc$703
- Takeda Pharmaceuticals U.S.A., Inc.$535
- Vanda Pharmaceuticals Inc.$493
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$456
- Otsuka America Pharmaceutical, Inc.$360
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,596100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 115 | $1,911 |
| Tris Pharma Inc | 15 | $703 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $535 |
| Vanda Pharmaceuticals Inc. | 24 | $493 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $456 |
| Otsuka America Pharmaceutical, Inc. | 17 | $360 |
| Alkermes, Inc. | 14 | $321 |
| Neurocrine Biosciences, Inc. | 11 | $236 |
| Teva Pharmaceuticals USA, Inc. | 9 | $201 |
| Idorsia Pharmaceuticals US Inc | 11 | $190 |
| Supernus Pharmaceuticals, Inc. | 15 | $189 |
| Bausch Health US, LLC | 8 | $148 |
| Lundbeck LLC | 6 | $116 |
| Sunovion Pharmaceuticals Inc. | 7 | $110 |
| Corium, LLC | 4 | $96 |
| Ironshore Pharmaceuticals Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Biogen | 3 | $66 |
| Noven Therapeutics, LLC | 3 | $61 |
| Almatica Pharma LLC | 2 | $60 |
| Johnson & Johnson | 3 | $54 |
| Eisai Inc. | 2 | $34 |
| Tempus AI, Inc | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$6,596 in reported general payments places this provider in the 95th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 12 | $32,931 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $2,573 |
| Bupropion XlBupropion Hcl | 24 | $560 |
| Lurasidone Hcl | 12 | $368 |
| Quetiapine Fumarate | 27 | $285 |
| Buspirone Hcl | 11 | $137 |
| Zolpidem Tartrate | 13 | $124 |
| Lithium Carbonate ErLithium Carbonate | 13 | $99 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $360 | $32,93112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 559 psychiatry providers in Colorado.
Other psychiatry in Denver
- Jeffrey RichmondDenver$424K
- Brenda CzabanDenver$25K
- Robert ClarkDenver$14K
- Stephen PopkinDenver$6K
- Sara MarkeyDenver$5K
- Joseph MendozzaDenver$3K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.